Browse by Person (creator, editor, contributor, etc.)
 | Up a level |
Jump to: Article
Number of items: 2.
Article
| Anderson, V. E. and Walton, M. I. and Eve, P. D. and Boxall, K. J. and Antoni, L. and Caldwell, J. J. and Aherne, W. and Pearl, L. H. and Oliver, A. W. and Collins, I. and Garrett, Michelle D. (2011) CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors. Cancer Research, 71 (2). pp. 463-472. ISSN 0008-5472. (doi:https://doi.org/10.1158/0008-5472.CAN-10-1252) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) |
| Yap, T. A. and Walton, M. I. and Hunter, L.-J. K. and Valenti, M. and de Haven Brandon, A. and Eve, P. D. and Ruddle, R. and Heaton, S. P. and Henley, A. and Pickard, L. and Vijayaraghavan, G. and Caldwell, J. J. and Thompson, N. T. and Aherne, W. and Raynaud, F. I. and Eccles, S. A. and Workman, P. and Collins, I. and Garrett, Michelle D. (2010) Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930. Molecular Cancer Therapeutics, 10 (2). pp. 360-371. ISSN 1535-7163. (doi:https://doi.org/10.1158/1535-7163.MCT-10-0760) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) |
